(R)-3-Fluoro-4-(pyrrolidin-2-yl)pyridine
95%
- Product Code: 123667
CAS:
1213375-37-1
| Molecular Weight: | 166.20 g./mol | Molecular Formula: | C₉H₁₁FN₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09257364 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry, protected from light |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate or building block in the synthesis of biologically active molecules, particularly those targeting neurological disorders. Its structure, featuring a pyrrolidine ring and a fluorinated pyridine moiety, makes it valuable for designing ligands that interact with specific receptors in the brain, such as nicotinic acetylcholine receptors. Researchers often explore its potential in developing treatments for conditions like Alzheimer's disease, Parkinson's disease, and other cognitive impairments. Additionally, its chiral nature allows for the study of stereoselective interactions in drug development, enhancing the efficacy and specificity of therapeutic agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $1,279.26 |
+
-
|
| 0.250 | 10-20 days | $1,918.88 |
+
-
|
(R)-3-Fluoro-4-(pyrrolidin-2-yl)pyridine
This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate or building block in the synthesis of biologically active molecules, particularly those targeting neurological disorders. Its structure, featuring a pyrrolidine ring and a fluorinated pyridine moiety, makes it valuable for designing ligands that interact with specific receptors in the brain, such as nicotinic acetylcholine receptors. Researchers often explore its potential in developing treatments for conditions like Alzheimer's disease, Parkinson's disease, and other cognitive impairments. Additionally, its chiral nature allows for the study of stereoselective interactions in drug development, enhancing the efficacy and specificity of therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :